Atlas Trials

BioVersys SAS

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch BioVersys SAS

RecordFirmDate
Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex (NCT07326540)BioVersys SAS2026-03-27
A Single Centre, Open-label, 2-period Fixed-sequence, Phase I Clinical Study to Evaluate the Effect of BV100 on the Pharmacokinetics of Polymyxin B in Healthy Volunteers (NCT07580586)BioVersys SAS2026-03-22
Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Healthy Male Subjects (NCT05087069)BioVersys SAS2021-10-08
Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Male Subjects (NCT04636983)BioVersys SAS2020-11-09

Track BioVersys SAS automatically

Every clearance here is in the API, with alerts when new ones post.